Home › B-Cell Lymphoma › Colorado › Denver
B-Cell Lymphoma clinical trials in Denver, CO
7 studies for B-Cell Lymphoma are looking for participants at sites in and around Denver (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
RecruitingPhase 1
- Colorado Blood Cancer Institute, Denver
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
RecruitingPhase 1/2
- Colorado Blood Cancer Institute, Denver
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
RecruitingPhase 3
- Colorado Blood Cancer Institute, Denver
DALY II USA/ MB-CART2019.1 for DLBCL
RecruitingPhase 2
- Colorado Blood Cancer Institute, Denver
A Phase 1/2 Study of STP938 (Dencatistat) for Adult Subjects With Relapsed/Refractory B-Cell and T-Cell Lymphomas
RecruitingPhase 1/2
- Colorado Blood Cancer Institute, Denver
SynKIR-310 for Relapsed/Refractory B-NHL
RecruitingPhase 1
- Colorado Blood Cancer Institute, part of Sarah Cannon Cancer Institute, Denver
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
RecruitingPhase 1
- Children's Hospital Colorado, Denver
B-Cell Lymphoma trials in other cities
- New York City, NY19 studies
- Houston, TX16 studies
- Chicago, IL12 studies
- Philadelphia, PA11 studies
- Nashville, TN11 studies
- Rochester, MN10 studies
- Baldwin Park, CA9 studies
- Milwaukee, WI9 studies
- Cleveland, OH9 studies
- Salt Lake City, UT8 studies
- Boston, MA8 studies
- Pittsburgh, PA7 studies
Other studies in Denver
- Metastatic Cancer29 studies
- Breast Cancer28 studies
- Multiple Myeloma27 studies
- Non-Small Cell Lung Cancer27 studies
- Colorectal Cancer23 studies
- Prostate Cancer19 studies
- Melanoma19 studies
- Cancer (all types)18 studies
- Ovarian Cancer16 studies
- Lung Cancer16 studies
- Endometrial Cancer15 studies
- Non-Hodgkin Lymphoma14 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.